Could the Endocannabinoid System Help Treat Malignant Hyperthermia?
A review proposes that cannabinoid receptor activation could counteract the dangerous calcium overload in malignant hyperthermia by reducing muscle calcium release through CB1-mediated inhibition of ryanodine receptor phosphorylation.
Quick Facts
What This Study Found
CB1 receptor activation inhibits PKA-mediated phosphorylation of RYR1 and L-type calcium channels, potentially reducing the excessive calcium release that causes malignant hyperthermia. Preclinical studies show CB1 agonism lowers body temperature and reduces cardiovascular stress.
Key Numbers
CB1 activation inhibits PKA-mediated phosphorylation of RYR1 and L-type calcium channels. TRPV1 antagonism or desensitization reduces sarcoplasmic reticulum calcium release.
How They Did This
Narrative review synthesizing molecular evidence linking endocannabinoid signaling to calcium homeostasis in skeletal muscle and its potential relevance to malignant hyperthermia.
Why This Research Matters
Malignant hyperthermia is life-threatening and has only one primary treatment (dantrolene), which has significant side effects. If cannabinoids can modulate the same calcium pathways, they could offer an adjunctive therapy.
The Bigger Picture
This review connects two previously separate fields: anesthesiology/pharmacogenetics and endocannabinoid research. If validated, it could represent an entirely new therapeutic approach for a rare but deadly condition.
What This Study Doesn't Tell Us
Theoretical review based on indirect molecular evidence. No studies have tested cannabinoids specifically in malignant hyperthermia models. The proposed mechanisms need experimental validation in RYR1-mutant models.
Questions This Raises
- ?Would cannabinoids be safe during anesthesia?
- ?Could they interfere with the triggering volatile anesthetics?
- ?What dose and timing would be needed for a protective effect?
Trust & Context
- Key Stat:
- CB1 activation inhibits the same PKA/RYR1 pathway that drives malignant hyperthermia
- Evidence Grade:
- Theoretical review proposing a novel mechanism; no direct experimental evidence in MH models yet.
- Study Age:
- 2025 review synthesizing current molecular evidence
- Original Title:
- The endocannabinoid system & malignant hyperthermia: From molecular signaling towards clinical implications.
- Published In:
- Progress in lipid research, 99, 101342 (2025)
- Authors:
- Dalle, Simon, Dalle, Sebastiaan(2)
- Database ID:
- RTHC-06292
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is malignant hyperthermia?
A life-threatening reaction to certain anesthetics that causes uncontrolled muscle contraction, dangerously high body temperature, and metabolic crisis. It is caused by genetic mutations in the ryanodine receptor (RYR1).
Could cannabis use protect against malignant hyperthermia?
This is purely theoretical at this point. The review proposes a molecular rationale but no studies have tested whether cannabinoids would actually prevent or treat MH episodes.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-06292APA
Dalle, Simon; Dalle, Sebastiaan. (2025). The endocannabinoid system & malignant hyperthermia: From molecular signaling towards clinical implications.. Progress in lipid research, 99, 101342. https://doi.org/10.1016/j.plipres.2025.101342
MLA
Dalle, Simon, et al. "The endocannabinoid system & malignant hyperthermia: From molecular signaling towards clinical implications.." Progress in lipid research, 2025. https://doi.org/10.1016/j.plipres.2025.101342
RethinkTHC
RethinkTHC Research Database. "The endocannabinoid system & malignant hyperthermia: From mo..." RTHC-06292. Retrieved from https://rethinkthc.com/research/dalle-2025-the-endocannabinoid-system-malignant
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.